FDA asks Congress for new SaMD pathway. Headspace $93M.

Issue 039. Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 53 percent open rate. Here's what's happening this week:

My first journalism job out of school was writing about the mobile industry, which has always centered on the big annual event, Mobile World Congress in Barcelona each February. If you haven't heard, the event organizers canceled it at the last minute because of coronavirus fears. Curious how this plays out in the coming years -- will epidemic-phobia crush the in-person meeting industry? (Travel industry pub Skift has a good piece on this if you're interested.)
This overview of reimbursement for mental health apps by Dr. John Torous is worth a quick read. It covers the current status of reimbursement in US (brief mentions of international efforts), including a list of relevant CPT codes. Torous argues that

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

FDA asks Congress for new SaMD pathway. Headspace $93M.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.